Hemo Organic Surges with Only Buy Orders, Approaching Multi-Day Upper Circuit

On 19 Nov 2025, Hemo Organic Ltd, a player in the Trading & Distributors sector, recorded a day change of 4.95%, markedly higher than the Sensex’s 0.27% gain on the same day. This surge is underscored by the absence of sellers, creating a scenario where only buy orders are queued, a rare phenomenon that often precedes sustained price ceilings or upper circuit limits in the Indian equity markets.

Examining the stock’s recent performance reveals a compelling pattern of consecutive gains. Over the past six trading days, Hemo Organic has delivered a cumulative return of 53.68%, a remarkable feat that highlights strong investor confidence and persistent demand. This streak of positive momentum contrasts sharply with the Sensex’s modest 0.51% gain over the last week, emphasising the stock’s outperformance within its sector and the broader market.

Further contextualising Hemo Organic’s performance, the stock has outpaced the Trading & Distributors sector by 4.85% today, reinforcing its position as a market leader in terms of price appreciation. The stock is currently trading just 2.47% below its 52-week high of ₹13.7, signalling proximity to a significant resistance level that may act as a catalyst for further price action.

From a technical standpoint, Hemo Organic is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages — indicating a strong bullish trend. This alignment of moving averages often serves as a confirmation of sustained upward momentum, attracting further buying interest from traders and institutional investors alike.

Looking at the medium-term performance, the stock has delivered a 39.71% return over the past week and an impressive 64.66% over the last month. These figures stand in stark contrast to the Sensex’s 0.51% and 1.13% returns over the same periods, respectively. Over three months, Hemo Organic’s 38.12% gain again outshines the Sensex’s 3.99%, underscoring the stock’s consistent outperformance.

On a longer horizon, the stock’s one-year return of 27.94% surpasses the Sensex’s 9.44%, although year-to-date figures show a 7.30% gain for Hemo Organic compared to the Sensex’s 8.65%. This suggests some recent moderation in gains but still reflects resilience amid broader market fluctuations.

However, the stock’s three-year, five-year, and ten-year performances reveal a different narrative, with returns of -8.42%, -18.48%, and -47.05% respectively, compared to the Sensex’s robust gains of 37.68%, 94.73%, and 228.54% over the same periods. This historical context highlights the stock’s cyclical nature and the importance of recent momentum in shaping current investor sentiment.

The current market scenario for Hemo Organic is particularly noteworthy due to the presence of only buy orders in the trading queue. This phenomenon typically indicates a lack of sellers willing to part with their shares at prevailing prices, often leading to an upper circuit situation where the stock price hits the maximum permissible increase for the day. Given the stock’s recent six-day consecutive gains and strong volume support, the possibility of a multi-day upper circuit cannot be discounted.

Such a scenario is significant for investors and market participants as it reflects extraordinary buying interest and a potential shift in market perception. The absence of sellers can be attributed to expectations of further price appreciation, creating a self-reinforcing cycle of demand. This dynamic often attracts momentum traders and can lead to heightened volatility in the short term.

Investors should also consider the stock’s market capitalisation grade of 4, which places it within the micro-cap segment. Micro-cap stocks are known for their volatility and potential for sharp price movements, both upwards and downwards. The Mojo Score of 33.0 and a recent adjustment in its evaluation from Strong Sell to Sell on 17 Nov 2025 reflect ongoing revisions in the stock’s assessment, signalling evolving market conditions and investor sentiment.

In summary, Hemo Organic Ltd’s current market behaviour, characterised by exclusive buy orders and a strong upward price trend, positions it as a stock to watch closely. The combination of technical strength, consecutive gains, and proximity to its 52-week high suggests that the stock may continue to experience significant price action in the near term. However, investors should remain mindful of the stock’s historical volatility and the broader market context when considering their positions.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →